What is the latest status of the project “Lilly Huntsville Pharmaceutical Manufacturing Facility”?

The status recorded for “Lilly Huntsville Pharmaceutical Manufacturing Facility” is planned.

What is the budget and commercial profile for the project “Lilly Huntsville Pharmaceutical Manufacturing Facility”?

Taiyo normalizes the budget of “Lilly Huntsville Pharmaceutical Manufacturing Facility” to USD 6000000000.

Where can I verify the source and access all details for “Lilly Huntsville Pharmaceutical Manufacturing Facility”?

This Taiyo project page references ConstructConnect along with the original URL (https://news.constructconnect.com/lilly-to-invest-6-billion-in-huntsville-al-pharma-manufacturing-facility). Taiyo standardizes official data into a consistent, searchable project profile.

Lilly Huntsville Pharmaceutical Manufacturing Facility

Sector: Manufacturing (Industrial) • Location: Huntsville, Alabama, United States

Source: ConstructConnect

Project

Planned

Lilly is investing $6 billion to build a new pharmaceutical manufacturing facility in Huntsville, Alabama. The facility will produce active pharmaceutical ingredients (API) including small-molecule synthetic and peptide medicines such as GLP-1 therapies. Construction is expected to start in 2026 and span six years, creating 3,000 construction jobs and 450 permanent operational jobs. The plant will

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Huntsville, Alabama, United States of America
Updated: 22 Jul 2026
Source: ConstructConnect

ConstructChat

Ask ConstructChat about Lilly Huntsville Pharmaceutical Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “Lilly Huntsville Pharmaceutical Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Huntsville, Alabama, United States. Taiyo aggregates data on it from ConstructConnect.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Lilly is investing $6 billion to build a new pharmaceutical manufacturing facility in Huntsville, Alabama. The facility will produce active pharmaceutical ingredients (API) including small-molecule synthetic and peptide medicines such as GLP-1 therapies. Construction is expected to start in 2026 and span six years, creating 3,000 construction jobs and 450 permanent operational jobs. The plant will integrate advanced technologies and focus on sustainability and carbon neutrality.
Original sector	Pharmaceutical Manufacturing
Budget

Location

Country	United States of America (USA)
State	Alabama
City	Huntsville

Source

Source	ConstructConnect
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-12-21

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Lilly Huntsville Pharmaceutical Manufacturing Facility

Ask ConstructChat about Lilly Huntsville Pharmaceutical Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States